Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Anthracyclines & Breast cancer / Mammacarcinoma

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Anthracyclines are still useful for curative-intent breast cancer treatment, but mainly when expected efficacy clearly outweighs long-term toxicity. In modern practice, they are often favored for biologically aggressive or high-risk disease, and more often omitted in lower-risk HER2-negative or selected HER2-positive patients (1).

References

(1) Hurvitz et al. 2021 npj Breast Cancer 7: 134

References (Sources)

A careful reassessment of anthracycline use in curable breast cancer
Hurvitz et al. 2021 npj Breast Cancer 7: 134

AI Chat

7/2/2026

Chat with our artificial intelligence:

Start chat!